Alliance Pharma PLC banner
A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.7 GBX Market Closed
Market Cap: £356.5m

Alliance Pharma PLC
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Alliance Pharma PLC
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
A
Alliance Pharma PLC
LSE:APH
Inventory
£22.5m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
14%
GlaxoSmithKline PLC
LSE:GSK
Inventory
£5.9B
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Inventory
$6.6B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
12%
Hikma Pharmaceuticals PLC
LSE:HIK
Inventory
$1.1B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
16%
Allergy Therapeutics PLC
LSE:AGY
Inventory
£13.9m
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
8%
Animalcare Group PLC
LSE:ANCR
Inventory
£14.2m
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
24%
No Stocks Found

Alliance Pharma PLC
Glance View

Market Cap
356.5m GBX
Industry
Pharmaceuticals

Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).

APH Intrinsic Value
101.44 GBX
Undervaluation 36%
Intrinsic Value
Price
A

See Also

What is Alliance Pharma PLC's Inventory?
Inventory
22.5m GBP

Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Inventory amounts to 22.5m GBP.

What is Alliance Pharma PLC's Inventory growth rate?
Inventory CAGR 10Y
14%

Over the last year, the Inventory growth was -12%. The average annual Inventory growth rates for Alliance Pharma PLC have been 2% over the past three years , 8% over the past five years , and 14% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett